Financière de Tubize SA (EBR:TUBAT)
0.1000
0.00 (0.00%)
At close: Aug 8, 2025
Intra-Cellular Therapies Revenue
Financière de Tubize had revenue of 13.26K EUR in the twelve months ending June 30, 2025. In the year 2024, Financière de Tubize had annual revenue of 13.26K.
Revenue
13.26K
Revenue Growth
n/a
P/S Ratio
505,664.72
Revenue / Employee
4.42K
Employees
3
Market Cap
6.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.26K | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 8.15K | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Anheuser-Busch InBev | 49.83B |
KBC Group NV | 11.31B |
UCB SA | 6.85B |
argenx SE | 2.66B |
ageas | 8.51B |
Elia Group | 4.15B |
D'Ieteren Group | 8.15B |
Groupe Bruxelles Lambert | 6.47B |